tiprankstipranks
Trending News
More News >
Titan Pharmaceuticals (TTNP)
NASDAQ:TTNP
US Market

Titan Pharmaceuticals (TTNP) Income Statement

Compare
791 Followers

Titan Pharmaceuticals Income Statement

Last quarter (Q4 2024), Titan Pharmaceuticals's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Titan Pharmaceuticals's net income was $-790.00K. See Titan Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 184.00K$ 60.00K$ 1.53M$ 4.84M
Gross Profit
$ 0.00$ 72.00K$ -136.00K$ 1.33M$ 4.37M
Operating Expenses
$ 4.56M$ 7.28M$ 10.29M$ 10.68M$ 11.72M
Depreciation and Amortization
$ 0.00$ 112.00K$ 196.00K$ 221.00K$ 292.00K
EBITDA
$ -4.56M$ -7.17M$ -10.04M$ -9.13M$ -7.06M
Operating Income
$ -4.56M$ -7.28M$ -10.23M$ -9.35M$ -7.35M
Other Income/Expenses
$ -149.00K$ 1.71M$ 29.00K$ 578.00K$ -56.00K
Pretax Income
$ -4.71M$ -5.57M$ -10.21M$ -8.78M$ -7.41M
Net Income
$ -4.71M$ -5.57M$ -10.18M$ -8.11M$ -20.73M
Per Share Metrics
Basic EPS
$ -5.23$ -7.41$ -15.15$ -16.68$ -109.88
Diluted EPS
$ -5.23$ -7.41$ -15.15$ -16.68$ -109.88
Weighted Average Shares Outstanding
899.00K 752.00K 671.70K 486.50K 188.65K
Weighted Average Shares Outstanding (Diluted)
899.00K 752.00K 671.70K 486.50K 188.65K
Currency in USD

Titan Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis